A new tryptamine analogue, N-salicyloyltryptamine (STP), a potential central nervous system (CNS) depressant, was tested in the pentylenetetrazol (PTZ) and maximal electroshock (MES) models of epilepsy in mice. When administered concurrently, STP (100 mg/kg ip) significantly reduced the number of animals that exhibited PTZ-induced seizures and eliminated the extensor reflex of maximal electric-induced seizures test in 50% of the experimental animals. In addition, it showed protection in the PTZ test by diminishing the death rate.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0091-3057(00)00484-6 | DOI Listing |
Publication Analysis
Top Keywords
anticonvulsant properties
4
properties n-salicyloyltryptamine
4
n-salicyloyltryptamine mice
4
mice tryptamine
4
tryptamine analogue
4
analogue n-salicyloyltryptamine
4
n-salicyloyltryptamine stp
4
stp potential
4
potential central
4
central nervous
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!